(2006) painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain
Manufactured under the strictest quality standards and packaged for multi-use integrity, it is the trusted choice for researchers and professionals who demand excellence
The Food and Drug Administration is weighing whether to allow compounding pharmacies to produce seven peptides that were previously banned over safety concerns
The FDAs pharmacy compounding advisory committee is scheduled to meet on 23-24 July and discuss seven peptides: BPC-157, KPV, TB-500, MOTs-C, Emideltide, Semax and Epitalon
Proper handling protocols are required when working with BPC-157 in lab settings
Vitamin B12, cyanocobalamin...............................50ug